Correlation Between Aerovate Therapeutics and Pharvaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Pharvaris BV, you can compare the effects of market volatilities on Aerovate Therapeutics and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Pharvaris.

Diversification Opportunities for Aerovate Therapeutics and Pharvaris

AerovatePharvarisDiversified AwayAerovatePharvarisDiversified Away100%
0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aerovate and Pharvaris is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Pharvaris go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Pharvaris

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.88 times more return on investment than Pharvaris. However, Aerovate Therapeutics is 1.14 times less risky than Pharvaris. It trades about -0.19 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.32 per unit of risk. If you would invest  258.00  in Aerovate Therapeutics on November 30, 2024 and sell it today you would lose (16.00) from holding Aerovate Therapeutics or give up 6.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Pharvaris BV

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15AVTE PHVS
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb2.352.42.452.52.552.62.652.7
Pharvaris BV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1618202224

Aerovate Therapeutics and Pharvaris Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-3.05-2.28-1.52-0.750.00.711.432.142.85 0.040.060.080.100.12
JavaScript chart by amCharts 3.21.15AVTE PHVS
       Returns  

Pair Trading with Aerovate Therapeutics and Pharvaris

The main advantage of trading using opposite Aerovate Therapeutics and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.
The idea behind Aerovate Therapeutics and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation